Researcher
Johan Van Weyenbergh
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Apr 2005 → Today
Projects
1 - 4 of 4
- Levaraging transcriptomic and metabolic analysis towards future therapeutics in HTLV-1 triggered Adult T-cell Lymphoma/LeukemiaFrom8 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Scrutinizing the role of mast cells during human and murine Leishmania infectionsFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- A transcriptomic approach to determine immunomodulatory therapeutic strategies in current and novel viral epidemics.From1 Jan 2015 → 16 May 2019Funding: IWT personal funding - strategic basic research grants
- Study of immune activation in HIV and HTLV infectionFrom1 Oct 2009 → 1 Oct 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
51 - 60 of 71
- Arginase I, Polyamine and Prostaglandin E2 Pathways Suppress the Inflammatory Response and Contribute to Diffuse Cutaneous Leishmaniasis(2015)
Authors: Johan Van Weyenbergh
Pages: 426 - 435 - Pathogen transcriptional profile in nasopharyngeal aspirates of children with acute respiratory tract infection(2015)
Authors: Winke Van der Gucht, Tim Dierckx, Marc Van Ranst, Lieselot Houspie, Johan Van Weyenbergh
Pages: 190 - 196 - CD8(+) Granzyme B+-Mediated Tissue Injury versus CD4(+)IFN gamma(+)-Mediated Parasite Killing in Human Cutaneous Leishmaniasis (vol 133 pg 1533, 2013)(2014)
Authors: Claire Da Silva Santos, Viviane Boaventura, Cristina Ribeiro Cardoso, Natalia Tavares, Morgana J Lordelo, Almerio Noronha, Jackson Costa, Valeria M Borges, Camila I de Oliveira, Johan Van Weyenbergh, et al.
Pages: 2850 - 2850 - SOD1 Plasma Level as a Biomarker for Therapeutic Failure in Cutaneous Leishmaniasis(2014)
Authors: Johan Van Weyenbergh
Pages: 306 - 10 - HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers.(2014)
Authors: Carolina Alvarez, Kristien Verdonck, Martín Tipismana, Michael Talledo, Jason Rosado, Daniel Clark, Johan Van Weyenbergh, Anne-Mieke Vandamme, Eduardo Gotuzzo
Pages: P37 - P37 - Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM/TSP.(2014)
Authors: Johan Van Weyenbergh, Daniele Decanine, Saul Velloso Schnitman, Ana Maria Moro, Jorge Kalil, Ramon A Kruschewsky, Bernardo Galvão-Castro
Pages: O40 - O40 - Superior antiviral and antiproliferative activity of IFN-beta vs. IFN-alpha in primary ATL cells occurs downstream of STAT1 signaling.(2014)
Authors: Ricardo Khouri, Gilvaneia Silva-Santos, Lourdes Farre, Achilea Bittencourt, Anne-Mieke Vandamme, Johan Van Weyenbergh
Pages: O22 - O22 - A selective defect in Fas-mediated apoptosis in HAM/TSP: An ex vivo, in vitro and in silico study.(2014)
Authors: Soraya Maria Menezes, Daniele Decanine, Ricardo Khouri, Saul Velloso Schnitman, Ramon A Kruschewsky, Anne-Mieke Vandamme, Bernardo Galvão-Castro, Johan Van Weyenbergh
Pages: P78 - P78 - CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis(2014)
Authors: Soraya Menezes, Anne-Mieke Vandamme, Johan Van Weyenbergh
Pages: 18 - 18 - Challenging the Th1 paradigm: A detrimental role for IFN-gamma and IFN-regulated CD64 in human leishmaniasis(2013)
Authors: Johan Van Weyenbergh, Theo Thepen, George Soares, Ricardo Khouri, Stefan Barth, Gilvaneia Silva-Santos, Jackson M Costa, Aldina Barral, Manoel Barral-Netto
Pages: 306 - 306